Search
for
Sort by
Research 61–90 of 115
- Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
- RAGE and Its Ligands in Melanoma
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Advantages of Functional Foods in Supporting and Maintaining Hair and Skin Health
- Successfully Nonsurgical Epidermoid Cyst Management with Recombinant Hydrolytic Enzymes: A Case Report
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- PROTACs: A novel strategy for cancer drug discovery and development
- Manganese-Doped Calcium Silicate Nanowire Composite Hydrogels for Melanoma Treatment and Wound Healing
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Topical delivery of nanoemulsions for skin cancer treatment
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Poster Presentations
- Current Biomedical Applications of 3D-Printed Hydrogels
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Mechanism of action and promising clinical application of melatonin from a dermatological perspective
- Prophylaxis and Management of Skin Toxicities
- YAP/TAZ Signalling Controls Epidermal Keratinocyte Fate